fmoc gly ser(psi(me,me)pro) oh acetate

Fmoc-Gly-Ser(psi(Me,Me)pro)-OH acetate is a dipeptide.

H-Ser-His-OH acetate is an endogenous metabolite hydrolysis cleavage activity.

Acetyl Ser-Asp-Lys-Pro is formed in bone marrow cells by enzymatic processing of thymosin β4. It inhibits the entry of pluripotent hemopoietic stem cells into S-phase of the cell cycle and protects against Ara-C lethality in mice.

Ac-Pro-Gly-Pro-OH is an acetyl-modified tripeptide compound that acts as a CXCR2 agonist.Ac-Pro-Gly-Pro-OH exhibits bactericidal and anti-inflammatory activity, inhibits apoptosis of immune cells, and suppresses the production of pro-inflammatory cytokines.Ac-Pro-Gly-Pro-OH has been used in the study of sepsis and inflammation in the lungs.

Boc-Gly-Gly-Phe-Gly-OH acetate (GGFG acetate) is a self-assembly of N- and C-protected tetrapeptide.

Abz-FR-K(Dnp)-P-OH acetate is an excellent angiotensin I-converting enzyme (ACE) substrate with a Km value of 4.0 μM and a kcat value of 210s-1.

Arg-Gly-Asp-Ser acetate is an integrin binding sequence that directly and specifically bind pro-caspase-8, pro-caspase-9 and pro-caspase-3, while it does not bind pro-caspase-1. Arg-Gly-Asp-Ser acetate inhibits integrin receptor function.

H-Lys-Trp-Lys-OH acetate is a peptide with antibacterial and antiviral activities.

H-Ala-Ala-Tyr-OH acetate can be synthesized mutant peptides.

Gly-Phe-Arg acetate is a superpotent synthetic tripeptide mimics of the mud-crab pumping pheromone.

Arg-Gly-Asp-Cys acetate inhibits platelet aggregation and fibrinogen binding. Arg-Gly-Asp-Cys acetate is the binding motif of fibronectin to cell adhesion molecules.

H-PRO-HIS-CYS-LYS-ARG-MET-OH acetate acts as antioxidant by reacting with active oxygen species such as superoxide and hydroxyl radicals.

Gly-Phe β-naphthylamide acetate is the substrate of Cathepsin C and can be used for research on the function of cathepsin C, intralysosomal hydrolysis and lysosomal membrane permeability.

Arg-Gly-Glu-Ser acetate is a RGD related peptide that is a control for the RGDS activity of fibrinogen binding to activated platelets.

Gly-Arg-Gly-Asp-Ser (GRGDS) acetate is a cell binding protein domain derived from the cell-binding region of fibronectin.

H-Ile-Pro-Pro-OH acetate is a angiotensin-converting enzyme inhibitor (ACE) of milk-derived tripeptides.

FOR-MET-PHE-OH acetate increases significantly granulocyte adhesiveness when used at a concentration chemotactically effective.

Arg-Gly-Asp-Ser is an integrin-binding sequence that inhibits integrin receptor function. It decreases systemic inflammation via inhibition of collagen-triggered activation of leukocytes and attenuates expression of inflammatory cytokines, MMP-9, and iNOS

Fmoc-Arg-OH (Fmoc-L-Arginine) (Fmoc-L-Arginine) is a used in peptide synthesis.

Fmoc-Cys(STmp)-OH is a cysteine derivative that can be used in the synthesis of bicyclic and linear peptides.

Z-Gly-Pro-Phe-Leu-CHO (Z-GPFL-CHO) is a tetrapeptide aldehyde serving as a selective and potent proteasome inhibitor, demonstrating inhibition constants (Ki) of 1.5 µM, 2.3 µM, and 40.5 µM for branched-chain amino acid-preferred, small neutral amino acid-preferred, and chymotrypsin-like activities, respectively, and an inhibitory concentration (IC50) of 3.1 µM for peptidyl-glutamyl peptide hydrolyzing activity [1].

H-Ile-Pro-Pro-OH, a milk-derived peptide, inhibits angiotensin-converting enzyme (ACE)[1] with an IC50 of 5 μM.

NF(N-Me)GA(N-Me)IL is a biologically active peptide, representing a modified segment (amino acids 22 to 27) of the human islet amyloid polypeptide (hIAPP) sequence NFGAIL. This modification includes N-methylations at G24 and I26, transforming the amyloidogenic and cytotoxic nature of the original sequence into a non-amyloidogenic and non-cytotoxic variant. Moreover, the peptide maintains the ability to bind with high affinity to full-length hIAPP, effectively inhibiting its fibril formation.

Arg-Gly-Asp-Ser (TFA) is an integrin binding sequence that inhibits integrin receptor function.

Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg-NH2 is a linear peptide derived from the laminin B1 chain, which disrupts tumor cell adherence and invasion into the basement membrane and exhibits anti-angiogenic properties [1].

pGlu-His-Pro-Gly-NH2, also known as Glp-His-Pro-Gly-NH2, is a tetrapeptide that promotes the release of gonadotropin, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) [1] [2].

Fmoc-N-Me-Ala-OH is available for the peptide-coupling reaction.

Val-Gly-Ser-Glu (NSC 350591), an ECF-A tetrapeptide, dose-dependently enhances the rosetting of human eosinophils with complement-coated sheep erythrocytes (EAC3b) without affecting neutrophils [1].

Tos-Gly-Pro-Arg-ANBA-IPA is a chromogenic peptide substrate. Tos-Gly-Pro-Arg-ANBA-IPA is used for the rapid and specific photometric assay of recombinant hirudin (r-hirudin).

FITC-Ahx-Gly-Arg-Gly-Asp-Ser-Pro, also known as FITC-linked GRGDSP, is a fluorescent peptide with integrin inhibitory properties. This compound impedes tumor cell adherence to endothelial blood vessel cells, potentially restricting metastasis [1].

Fmoc-N-Me-Phe-OH (Fmoc-N-methyl-L-phenylalanine) is a Malaria Parasite inhibitor.

Boc-Gly-Gly-Phe-Gly-OH TFA is a self-assembly of N-protected and C-protected tetrapeptides and is a protease cleaved connector for antibody-drug binding (ADC).

Fmoc-Phe(4-CN)-OH is an N-Fmoc protected phenylalanine derivative and potentially useful synthetic intermediate

H-Val-Thr-Cys-Gly-OH is a cell attachment peptide that functions as a bioactive molecule promoting cell adhesion and facilitating various cell interactions [1].

H-Gly-Pro-Arg-Pro-NH2 is a tetrapeptide that replicates the N-terminal Gly-Pro-Arg sequence in the alpha (α) chain of fibrin and inhibits its polymerization [1].

FMoc-Arg(Tos)-OH is a synthetic amino acid used in peptide synthesis, biochemistry and molecular biology. It is a Fmoc-protected amino acid used as an intermediate in peptide and protein synthesis for solid-phase peptide synthesis.

Arg-gly-glu -Ser(TFA) is a RGD related polypeptide that controls the inhibition of fibrinogen binding to activated platelets by RGDS.

Cyclo(Phe-Pro) acetate(14705-60-3 free base), known as a secondary metabolite of some bacteria and fungi, is also produced by Vibrio vulnificus.

Fmoc-N-Me-Leu-OH is available for the peptide-coupling reaction.

Fmoc-Gly-Thr(psi(Me,Me)pro)-OH is a polypeptide composed of two amino acids.

Mc-Gly-Gly-Phe-Gly-PAB-OH, also known as Mc-GGFG-PAB-OH, serves as a cleavable ADC linker exclusively employed in the synthesis of antibody-drug conjugates (ADCs).

Fmoc-Thr(GalNAc(Ac)3-β-D)-OH impedes the proliferation of cancer cells by selectively interacting with complex oncogenic pathways and enhancing the immune response [1].

Tripeptide 29 (HGly-Pro-Hyp-OH) is a bioactive peptide with oral efficacy against UVB-induced skin aging and is utilized as a cosmetic ingredient [1].

Ser-parafluoroPhe-Aad-Leu-Arg-Asn-Pro-NH2 is a biologically active peptide. Structure-activity studies of the thrombin receptor-tethered ligand SFLLRNP underscored the pivotal role of the Phe-2-phenyl group in receptor recognition, while substitution with para-fluorophenylalanine [(p-F)Phe] augmented its activity.

SNNF(N-Me)GA(N-Me)ILSS is a biologically active peptide comprising double N-methylated derivatives of an amyloidogenic and cytotoxic partial IAPP sequence.

F(N-Me)GA(N-Me)IL is a bioactive peptide whose double N-methylated derivatives of the partial IAPP sequence lack β-sheet structure, amyloidogenicity, and cytotoxicity. These derivatives can interact with the native sequences to inhibit amyloid formation.

SNNF(N-Me)GA(N-Me)IL is a biologically active peptide comprising double N-methylated derivatives of a partial IAPP sequence known to be amyloidogenic and cytotoxic.

Gly-Arg-Gly-Asp-Ser (GRGDS) is a cell binding protein domain derived from the cell-binding region of fibronectin. Osteopontin uses this motif for cell adhesion.

H-Pro-Gly-Pro-OH, a collagen-derived matrikine, traditionally acts as a neutrophil chemoattractant, guiding these cells to target locations to orchestrate localized repair responses. Additionally, this compound initiates the transcription of neurotrophins and their receptor genes following cerebral ischemia [1] [2].

H-Pro-Pro-Gln-OH is an oligopeptide that exhibits potent inhibitory activity against dipeptidyl peptidase-IV (DPP-IV) [1].